Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...

A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

Researchers said the study backs up anecdotal evidence from patients and doctors that semaglutide can lead to a sudden loss ...

Oral semaglutide is taken daily and, compared with injections, tends to be as effective, but shows greater stomach-related side effects. Weight loss injections are essentially the opposite of ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.

However, another study found that 56.2% of patients who ceased semaglutide injections for one year remained at around the same weight or continued to lose more after treatment. Some research shows ...

The FDA has determined that the nationwide shortage of semaglutide injection, used for both diabetes and weight loss, is resolved after more than two years of limited availability due to high demand.

Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.